The organ donation boom complicates the boundary between life and death. Emily Hoffman, a 34-year-old woman, was walking home from lunch in Pittsburgh when she was struck by a driver and went into cardiac arrest. Despite multiple surgeries and ventilator support, she suffered strokes and severe brain injury, leading her family to decide on donation after circulatory death (DCD).
This method, where death is declared after circulation ceases, has transformed American transplantation in the last decade. DCD now accounts for nearly half of all organ donors who have died in the United States, up from just 219 organs in 2000 to nearly 17,000 in 2025. This growth has saved lives, but it has also raised questions about medicine's ability to manage the boundary between life and death.
The breakthrough in DCD came with the development of machines and surgical techniques that could preserve organs outside the body, making DCD more viable. However, the process of donation after circulatory death creates a complex situation where one set of hands cares for the dying patient, while another prepares to recover and transplant their organs.
The controversy surrounding DCD lies in the use of normothermic regional perfusion (NRP), a technique that restores circulation inside the dead donor's body before organ removal. This raises questions about whether the heart is still considered dead or if it has been revived, potentially leading to the restoration of consciousness. The debate centers around the risk of pain or suffering during the organ procurement process.
The patchwork of DCD practices across the United States highlights the need for standardization to ensure patient safety and protect public trust. While DCD has led to more organs, shorter waits, and saved thousands of lives, its future depends on the ability of its proponents to address these concerns and maintain the delicate balance between patient care and organ recovery.
